Widespread distribution of reticulon-3 in various neurodegenerative diseases

Neuropathology

Volumn 30, Issue 6, 2010, Pages 574-579

  Heath, Jonathon E ^a   Siedlak, Sandra L ^b   Zhu, Xiongwei ^b   Lee, Hyoung Gon ^b   Thakur, Akanksha ^b   Yan, Riqiang ^c   Perry, George ^b,d   Smith, Mark A ^b   Castellani, Rudy J ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d University of San Antonio   (United States)

Author keywords

Alzheimer's disease; Amyloid; Diffuse Lewy body disease; Dystrophic neurite; Oxidative stress; Parkinson's disease; Reticulon

Indexed keywords

ALPHA SYNUCLEIN; MEMBRANE PROTEIN; RETICULON 3; TAU PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; BRAIN REGION; CELLULAR DISTRIBUTION; DEGENERATIVE DISEASE; DIFFUSE LEWY BODY DISEASE; DOWNSTREAM PROCESSING; ENDOPLASMIC RETICULUM STRESS; GLIA CELL; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; NEURITE; NEUROPIL; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN; CARRIER PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INCLUSION BODIES; LEWY BODY DISEASE; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; NEURONS; PARKINSON DISEASE;

EID: 78649577621     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2010.01107.x     Document Type: Article

References (24)

1. Wakana Y, Koyama S, Nakajima K et al. Reticulon 3 is involved in membrane trafficking between the endoplasmic reticulum and Golgi. Biochem Biophys Res Commun 2005; 334: 1198-1205.
2. Kiseleva E, Morozova KN, Voeltz GK, Allen TD, Goldberg MW. Reticulon 4a/NogoA locates to regions of high membrane curvature and may have a role in nuclear envelope growth. J Struct Biol 2007; 160: 224-235.
3. Tagami S, Eguchi Y, Kinoshita M, Takeda M, Tsujimoto Y. A novel protein, RTN-XS, interacts with both Bcl-XL and Bcl-2 on endoplasmic reticulum and reduces their anti-apoptotic activity. Oncogene 2000; 19: 5736-5746.
4. Wan Q, Kuang E, Dong W et al. Reticulon 3 mediates Bcl-2 accumulation in mitochondria in response to endoplasmic reticulum stress. Apoptosis 2007; 12: 319-328.
5. GrandPre T, Nakamura F, Vartanian T, Strittmatter SM. Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature 2000; 403: 439-444.
6. Prinjha R, Moore SE, Vinson M et al. Inhibitor of neurite outgrowth in humans. Nature 2000; 403: 383-384.
7. Acevedo L, Yu J, Erdjument-Bromage H et al. A new role for Nogo as a regulator of vascular remodeling. Nat Med 2004; 10: 382-388.
8. He W, Lu Y, Qahwash I, Hu XY, Chang A, Yan R. Reticulon family members modulate BACE1 activity and amyloid-beta peptide generation. Nat Med 2004; 10: 959-965.
9. Li S, Liu BP, Budel S et al. Blockade of Nogo-66, myelin-associated glycoprotein, and oligodendrocyte myelin glycoprotein by soluble Nogo-66 receptor promotes axonal sprouting and recovery after spinal injury. J Neurosci 2004; 24: 10511-10520.
10. Murayama KS, Kametani F, Saito S, Kume H, Akiyama H, Araki W. Reticulons RTN3 and RTN4-B/C interact with BACE1 and inhibit its ability to produce amyloid beta-protein. Eur J Neurosci 2006; 24: 1237-1244.
11. Hu X, Shi Q, Zhou X et al. Transgenic mice overexpressing reticulon 3 develop neuritic abnormalities. EMBO J 2007; 26: 2755-2767.
12. Shi Q, Prior M, He W, Tang X, Hu X, Yan R. Reduced amyloid deposition in mice overexpressing RTN3 is adversely affected by preformed dystrophic neurites. J Neurosci 2009; 29: 9163-9173.
13. He W, Shi Q, Hu X, Yan R. The membrane topology of RTN3 and its effect on binding of RTN3 to BACE1. J Biol Chem 2007; 282: 29144-29151.
14. Kume H, Konishi Y, Murayama KS, Kametani F, Araki W. Expression of reticulon 3 in Alzheimer's disease brain. Neuropathol Appl Neurobiol 2009; 35: 178-188.
15. Smith MA, Kutty RK, Richey PL et al. Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease. Am J Pathol 1994; 145: 42-47.
16. Castellani R, Smith MA, Richey PL, Perry G. Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease. Brain Res 1996; 737: 195-200.
17. Shi Q, Hu X, Prior M, Yan R. The occurrence of aging-dependent reticulon 3 immunoreactive dystrophic neurites decreases cognitive function. J Neurosci 2009; 29: 5108-5115.
18. Fukumoto H, Rosene DL, Moss MB, Raju S, Hyman BT, Irizarry MC. Beta-secretase activity increases with aging in human, monkey, and mouse brain. Am J Pathol 2004; 164: 719-725.
19. Banhegyi G, Mandl J, Csala M. Redox-based endoplasmic reticulum dysfunction in neurological diseases. J Neurochem 2008.
20. De Felice FG, Wu D, Lambert MP et al. Alzheimer's disease-type neuronal tau hyperphosphorylation induced by Abeta oligomers. Neurobiol Aging 2007.
21. Castellani RJ, Lee HG, Zhu X, Perry G, Smith MA. Alzheimer disease pathology as a host response. J Neuropathol Exp Neurol 2008; 67: 523-531.
22. Lee HG, Zhu X, Castellani RJ, Nunomura A, Perry G, Smith MA. Amyloid-beta in Alzheimer disease: the null versus the alternate hypotheses. J Pharmacol Exp Ther 2007; 321: 823-829.
23. Nunomura A, Castellani RJ, Lee HG et al. Neuropathology in Alzheimer's disease: awaking from a hundred-year-old dream. Sci Aging Knowledge Environ 2006; 2006
24. Castellani RJ, Lee HG, Zhu X, Nunomura A, Perry G, Smith MA. Neuropathology of Alzheimer disease: pathognomonic but not pathogenic. Acta Neuropathol 2006; 111: 503-509.